Zura Bio Ltd (ZURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,650 | -52,403 | -60,563 | -27,333 | 6,849 |
| Depreciation Amortization | 49 | 9 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 70 |
| Other Working Capital | -3,634 | 2,307 | 5,116 | 3,541 | -236 |
| Other Operating Activity | 7,420 | 22,011 | 40,393 | 22,590 | -7,781 |
| Operating Cash Flow | $-64,815 | $-28,076 | $-15,054 | $-1,202 | $-1,098 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -113 | -75 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -5,000 | -8,000 | -12,000 | N/A |
| Other Investing Activity | 0 | -5,000 | -8,000 | -12,000 | -139,380 |
| Investing Cash Flow | $-113 | $-5,075 | $-8,000 | $-12,000 | $-139,380 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 7,600 | -117 |
| Common Stock Issued | 5,203 | 110,787 | 132,477 | N/A | 138,000 |
| Other Financing Activity | -7,366 | -944 | -11,184 | 7,169 | 3,325 |
| Financing Cash Flow | $-2,163 | $109,843 | $121,293 | $14,769 | $141,207 |
| Beginning Cash Position | 176,498 | 99,806 | 1,567 | N/A | N/A |
| End Cash Position | 109,407 | 176,498 | 99,806 | 1,567 | 729 |
| Net Cash Flow | $-67,091 | $76,692 | $98,239 | $1,567 | $729 |
| Free Cash Flow | |||||
| Operating Cash Flow | -64,815 | -28,076 | -15,054 | -1,202 | -1,098 |
| Capital Expenditure | -113 | -75 | N/A | N/A | N/A |
| Free Cash Flow | -64,928 | -28,151 | -15,054 | -1,202 | -1,098 |